SENSEX 80206.91 (0.44)

Nifty 50 24475.2 (0.46)

Nifty Bank 55226.05 (0.40)

Nifty IT 34537.75 (0.40)

Nifty Midcap 100 56328.6 (0.58)

Nifty Next 50 66034.55 (0.79)

Nifty Pharma 21550.65 (0.69)

Nifty Smallcap 100 17449.1 (0.12)

Indian Market
Nifty 50 48,450.45 +541.45 | 0.85%
Nifty 100 48,450.45 +541.45 | 0.85%
Sensex 48,450.45 +541.45 | 0.85%
Sensex 48,450.45 +541.45 | 0.85%
Global Market
Nifty 50 48,450.45 +541.45 | 0.85%
Nifty 100 48,450.45 +541.45 | 0.85%
Sensex 48,450.45 +541.45 | 0.85%
Sensex 48,450.45 +541.45 | 0.85%
News
  • Investment Services
  • Empower your investments with real-time data and personalized strategies. Join us at JustTrade and shape your
  • Investment Services
  • Empower your investments with real-time data and personalized strategies. Join us at JustTrade and shape your
  • Investment Services
  • Empower your investments with real-time data and personalized strategies. Join us at JustTrade and shape your
AstraZeneca Pharma to launch Eculizumab (Soliris) in India
(15:43, 06 Aug 2025)

 AstraZeneca Pharma India announced that it will launch Eculizumab (Soliris) in August 2025 in India.

Eculizumab (Soliris) is indicated for the treatment of patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) and atypical Hemolytic Uremic Syndrome (aHUS) to inhibit complement - mediated thrombotic microangiopathy.

Powered by Capital Market - Live News